3.9 Article

Performance Evaluation of the New Chemiluminescence Immunoassay CL-1200i for HBV, HIV Panels

期刊

DISEASES
卷 11, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/diseases11020083

关键词

HIV detection; HBV detection; chemiluminescence immunoassay

向作者/读者索取更多资源

Infectious diseases like HIV and HBV have a global impact on public health and healthcare costs. Timely diagnosis plays a central role in controlling the spread of these infections. This study compared the performance of the Abbott system and the new analyser Mindray 1200i in detecting HBV and HIV infections. Clinical serum samples from randomly selected patients were tested and compared with the routine instrument, Abbott Architect. The results showed that the Mindray CL-1200i platform offers high-level performance with accurate and consistent test results, making it a valuable tool for routine analysis.
Infectious diseases such as HIV and HBV are a global concern for their impact in terms of public health and costs for national health services. A central role in contrasting the spread of the infections is represented by timely diagnosis. The speed of detection depends on several factors including the type of test used. Antibody response to hepatitis B surface antigens (anti-HBs) is an important serological marker used for HBV-infection detection. The aim of this study was to compare the performance of the Abbott system and of the new analyser Mindray 1200i in the detection of HBV- and HIV-infections. Clinical serum samples were collected from patients randomly selected from PTV University Hospital of University of Rome Tor Vergata and tested for HBV and HIV antibodies. Samples were evaluated by Mindray Cl 1200i CLIA screening tests for HBV and HIV and the results were compared with the Abbott Architect analytical system, the routine instrument of the hospital clinical biochemistry laboratory. Precision study, linearity, and carryover were performed on the results obtained. The agreement between the results of the Abbott and Mindray CLIA ranged from 99% to 100% and the discrepancy rate from 0% to 1%. The measurements demonstrated that the Mindray CL-1200i platform offers high-level performance with accurate and consistent test results and could represent a valuable tool if implemented in routine analysis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.9
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据